These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20714117)

  • 21. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform.
    Ning YJ; Wang M; Deng M; Shen S; Liu W; Cao WC; Deng F; Wang YY; Hu Z; Wang H
    J Mol Cell Biol; 2014 Aug; 6(4):324-37. PubMed ID: 24706939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.
    Otsuka M; Kato N; Moriyama M; Taniguchi H; Wang Y; Dharel N; Kawabe T; Omata M
    Hepatology; 2005 May; 41(5):1004-12. PubMed ID: 15841462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
    Qi D; Hu L; Jiao T; Zhang T; Tong X; Ye X
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
    Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions.
    Kaukinen P; Sillanpää M; Nousiainen L; Melén K; Julkunen I
    J Med Virol; 2013 Jan; 85(1):71-82. PubMed ID: 23096996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.
    Johnson J; Albarani V; Nguyen M; Goldman M; Willems F; Aksoy E
    J Biol Chem; 2007 May; 282(20):15022-32. PubMed ID: 17296604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.
    Ding Q; Cao X; Lu J; Huang B; Liu YJ; Kato N; Shu HB; Zhong J
    J Hepatol; 2013 Jul; 59(1):52-8. PubMed ID: 23542348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
    Wang Y; Ye L; Wang X; Li J; Song L; Ho W
    Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
    Binder M; Kochs G; Bartenschlager R; Lohmann V
    Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human DEAD box helicase 3 couples IκB kinase ε to interferon regulatory factor 3 activation.
    Gu L; Fullam A; Brennan R; Schröder M
    Mol Cell Biol; 2013 May; 33(10):2004-15. PubMed ID: 23478265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCPIP1 negatively regulate cellular antiviral innate immune responses through DUB and disruption of TRAF3-TBK1-IKKε complex.
    Chen X; Zhao Q; Xie Q; Xing Y; Chen Z
    Biochem Biophys Res Commun; 2018 Sep; 503(2):830-836. PubMed ID: 29920243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.
    Prins KC; Cárdenas WB; Basler CF
    J Virol; 2009 Apr; 83(7):3069-77. PubMed ID: 19153231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.
    Civas A; Génin P; Morin P; Lin R; Hiscott J
    J Biol Chem; 2006 Feb; 281(8):4856-66. PubMed ID: 16380379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity.
    Liu D; Sheng C; Gao S; Yao C; Li J; Jiang W; Chen H; Wu J; Pan C; Chen S; Huang W
    Mol Cell Biol; 2015 Jul; 35(14):2400-13. PubMed ID: 25939384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DDX19 Inhibits Type I Interferon Production by Disrupting TBK1-IKKε-IRF3 Interactions and Promoting TBK1 and IKKε Degradation.
    Zhang K; Zhang Y; Xue J; Meng Q; Liu H; Bi C; Li C; Hu L; Yu H; Xiong T; Yang Y; Cui S; Bu Z; He X; Li J; Huang L; Weng C
    Cell Rep; 2019 Jan; 26(5):1258-1272.e4. PubMed ID: 30699353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1.
    Xiang W; Zhang Q; Lin X; Wu S; Zhou Y; Meng F; Fan Y; Shen T; Xiao M; Xia Z; Zou J; Feng XH; Xu P
    Sci Adv; 2016 Jul; 2(7):e1501889. PubMed ID: 27419230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.
    Wang H; Ryu WS
    PLoS Pathog; 2010 Jul; 6(7):e1000986. PubMed ID: 20657822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation.
    Chang TH; Liao CL; Lin YL
    Microbes Infect; 2006 Jan; 8(1):157-71. PubMed ID: 16182584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.